Chronic Disease with the Immune System in Internal Organs

키워드

참고문헌 (107)

1. Chen L, "Inflammatory responses and inflammation-associated diseases in organs", Oncotarget, 9, pp.7204~7218 (2018)
2. Bennett JM, "Inflammation-Nature’s Way to Efficiently Respond to All Types of Challenges : Implications for Understanding and Managing"the Epidemic"of Chronic Diseases", Front Med(Lausanne), 5, pp.316~ (2018)
3. Liu CH, "Innate immunity in tuberculosis : host defense vs pathogen evasion", Cell Mol Immunol, 14, pp.963~975 (2017)
4. Han Y, "Innate and Adaptive Immune Responses Against Microsporidia Infection in Mammals", Front Microbiol, 11, pp.1468~ (2020)
5. Sansbury BE, "Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology", Circ Res, 119, pp.113~130 (2016)
6. Hanahan D, "Hallmarks of cancer : the next generation", Cell, 144, pp.646~674 (2011)
7. Hanahan D, "Hallmarks of Cancer : New Dimensions", Cancer Discov, 12, pp.31~46 (2022)
8. Grivennikov SI, "Immunity, inflammation, and cancer", Cell, 140, pp.883~899 (2010)
9. Multhoff G, "Radiation, inflammation, and immune responses in cancer", Front Oncol, 2, pp.58~ (2012)
10. Greten FR, "Inflammation and Cancer : Triggers, Mechanisms, and Consequences", Immunity, 51, pp.27~41 (2019)
11. Zhao H, "Inflammation and tumor progression : signaling pathways and targeted intervention", Signal Transduct Target Ther, 6, pp.263~ (2021)
12. Ma Y, "Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells", Immunity, 38, pp.729~741 (2013)
13. Luster AD, "Immune cell migration in inflammation : present and future therapeutic targets", Nat Immunol, 6, pp.1182~1190 (2005)
14. Bremnes RM, "The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis : emphasis on non-small cell lung cancer", J Thorac Oncol, 6, pp.824~833 (2011)
15. Leigh T, "Resolution of inflammation in immune and nonimmune cells by interleukin-19", Am J Physiol Cell Physiol, 319, pp.C457~C464 (2020)
16. Zhang JM, "Cytokines, inflammation, and pain", Int Anesthesiol Clin, 45, pp.27~37 (2007)
17. Arango Duque G, "Macrophage cytokines : involvement in immunity and infectious diseases", Front Immunol, 5, pp.491~ (2014)
18. Chen LJ, "The protective effect of lidocaine on lipopolysaccharide-induced acute lung injury in rats through NF-kappaB and p38MAPK signaling pathway and excessive inflammatory responses", Eur Rev Med Pharmacol Sci, 22, pp.2099~2108 (2018)
19. Catanzaro M, "Immune response in COVID-19 : addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2", Signal Transduct Target Ther, 5, pp.84~ (2020)
20. Belkaid Y, "Regulatory T cells and infection : a dangerous necessity", Nat Rev Immunol, 7, pp.875~888 (2007)
21. Rudensky AY, "Regulatory T cells and Foxp3", Immunol Rev, 241, pp.260~268 (2011)
22. Salomon BL, "Targeting inflammation to improve regulatory T cell therapy for immunopathologies", Proc Natl Acad Sci U S A, 119, pp.e2215271119~ (2022)
23. Li W, "The Regulatory T Cell in Active Systemic Lupus Erythematosus Patients : A Systemic Review and Meta-Analysis", Front Immunol, 10, pp.159~ (2019)
24. Kanjana K, "Inhibitory activity of FOXP3+regulatory T cells reveals high specificity for displaying immune tolerance in remission state rheumatoid arthritis", Sci Rep, 10, pp.19789~ (2020)
25. Meyer A, "Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors", Ann Rheum Dis, 80, pp.e196~ (2021)
26. Collison LW, "IL-35-mediated induction of a potent regulatory T cell population", Nat Immunol, 11, pp.1093~1101 (2010)
27. Elrefaei M, "TGF-beta and IL-10 production by HIV-specific CD8+ T cells is regulated by CTLA-4 signaling on CD4+ T cells", PLoS One, 4, pp.e8194~ (2009)
28. Demols A, "CD4(+)T cells play an important role in acute experimental pancreatitis in mice", Gastroenterology, 118, pp.582~590 (2000)
29. Xue J, "Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis", Nat Commun, 6, pp.7158~ (2015)
30. Koda Y, "CD8(+)tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells", Nat Commun, 12, pp.4474~ (2021)
31. Duggan SN, "Chronic pancreatitis : A diagnostic dilemma", World J Gastroenterol, 22, pp.2304~2313 (2016)[DOI]
32. Kleeff J, "Chronic pancreatitis", Nat Rev Dis Primers, 3, pp.17060~ (2017)
33. Irving HM, "Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis", JOP, 10, pp.387~392 (2009)
34. Karpinska M, "Pancreas-Its Functions, Disorders, and Physiological Impact on the Mammals’ Organism", Front Physiol, 13, pp.807632~ (2022)
35. Pia V Röder, "Pancreatic regulation of glucose homeostasis", Experimental and Molecular Medicine, 48, pp.1~19 (2016), 생화학분자생물학회
36. Lee B, "Distinct immune characteristics distinguish hereditary and idiopathic chronic pancreatitis", J Clin Invest, 130, pp.2705~2711 (2020)
37. Makhija R, "Cytokine storm in acute pancreatitis", J Hepatobiliary Pancreat Surg, 9, pp.401~410 (2002)
38. Pastor CM, "Role of macrophage inflammatory peptide-2in cerulein-induced acute pancreatitis and pancreatitis-associated lung injury", Lab Invest, 83, pp.471~478 (2003)
39. Sendler M, "Cathepsin B-Mediated Activation of Trypsinogen in Endocytosing Macrophages Increases Severity of Pancreatitis in Mice", Gastroenterology, 154, pp.704~718 (2018)
40. Glaubitz J, "Experimental pancreatitis is characterized by rapid T cell activation, Th2 differentiation that parallels disease severity, and improvement after CD4(+)T cell depletion", Pancreatology, 20, pp.1637~1647 (2020)
41. Glaubitz J, "In mouse chronic pancreatitis CD25(+)FOXP3(+)regulatory T cells control pancreatic fibrosis by suppression of the type 2 immune response", Nat Commun, 13, pp.4502~ (2022)
42. Wei X, "B and NK Cells Closely Correlate with the Condition of Patients with Acute Pancreatitis", Gastroenterol Res Pract, 2019, pp.7568410~ (2019)
43. Lopez-Soldado I, "Maintenance of liver glycogen during long-term fasting preserves energy state in mice", FEBS Lett, 594, pp.1698~1710 (2020)
44. Gowda S, "A review on laboratory liver function tests", Pan Afr Med J, 3, pp.17~ (2009)
45. Gao B, "Alcoholic liver disease : pathogenesis and new therapeutic targets", Gastroenterology, 141, pp.1572~1585 (2011)
46. Yuen MF, "Hepatitis B virus infection", Nat Rev Dis Primers, 4, pp.18035~ (2018)
47. Anstee QM, "From NASH to HCC : current concepts and future challenges", Nat Rev Gastroenterol Hepatol, 16, pp.411~428 (2019)
48. Gao J, "Risk factors of hepatocellular carcinoma-current status and perspectives", Asian Pac J Cancer Prev, 13, pp.743~752 (2012)
49. Thimme R, "CD8(+)T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection", J Virol, 77, pp.68~76 (2003)
50. Fisicaro P, "Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B", Gastroenterology, 138, pp.682~693 (2010)
51. Schurich A, "Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection", Hepatology, 53, pp.1494~1503 (2011)
52. Longhi MS, "Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis", J Autoimmun, 25, pp.63~71 (2005)
53. Franceschini D, "PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV", J Clin Invest, 119, pp.551~564 (2009)
54. Xu D, "Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B", J Immunol, 177, pp.739~747 (2006)
55. Tang TJ, "The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection", J Viral Hepat, 10, pp.159~167 (2003)
56. Li Y, "Macrophages activated by hepatitis B virus have distinct metabolic profiles and suppress the virus via IL-1beta to downregulate PPARalpha and FOXO3", Cell Rep, 40, pp.111068~ (2022)
57. Safadi R, "Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes", Gastroenterology, 127, pp.870~882 (2004)
58. Imamura M, "Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats", Gastroenterology, 128, pp.138~146 (2005)
59. Tomita K, "Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice", Gut, 55, pp.415~424 (2006)
60. Ikeno Y, "Foxp3+ Regulatory T Cells Inhibit CCl4-Induced Liver Inflammation and Fibrosis by Regulating Tissue Cellular Immunity", Front Immunol, 11, pp.584048~ (2020)
61. Gu L, "Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17", Treg cell balance, 2016, pp.14, 1153~1161
62. Jiang G, "Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner", Transplantation, 86, pp.1492~1502 (2008)
63. Langhans B, "Regulatory CD4+ T cells modulate the interaction between NK cells and hepatic stellate cells by acting on either cell type", J Hepatol, 62, pp.398~404 (2015)
64. Wei Y, "The antifibrotic role of natural killer cells in liver fibrosis", Exp Biol Med(Maywood), 247, pp.1235~1243 (2022)
65. Gur C, "NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis", Gut, 61, pp.885~893 (2012)
66. "Anatomy, Thorax, Lungs"[URL]
67. Cai P, "Three-dimensional analysis of the segmental arrangement of lower lung lobes in human fetuses : is this arrangement a miniature version of adult morphology?", J Anat, 236, pp.1021~1034 (2020)
68. Patwa A, "Anatomy and physiology of respiratory system relevant to anaesthesia", Indian J Anaesth, 59, pp.533~541 (2015)
69. Aghasafari P, "A review of inflammatory mechanism in airway diseases", Inflamm Res, 68, pp.59~74 (2019)
70. Mathioudakis AG, "Current developments and future directions in COPD", Eur Respir Rev, 29 (2020)
71. Quaderi SA, "The unmet global burden of COPD", Glob Health Epidemiol Genom, 3, pp.e4~ (2018)
72. Jenkins C, "Drugs for chronic obstructive pulmonary disease", Aust Prescr, 40, pp.15~19 (2017)
73. Di Stefano A, "T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients", Clin Exp Immunol, 157, pp.316~324 (2009)
74. Zhang J, "Increased expression of CD4+IL-17+ cells in the lung tissue of patients with stable chronic obstructive pulmonary disease(COPD)and smokers", Int Immunopharmacol, 15, pp.58~66 (2013)
75. Silva LEF, "Th17", Treg imbalance in COPD development : suppressors of cytokine signaling and signal transducers and activators of transcription proteins, 2020, pp.10, 15287~
76. Sales DS, "Regulatory T-Cell Distribution within Lung Compartments in COPD", COPD, 14, pp.533~542 (2017)
77. Zheng X, "Dendritic cells and Th17", Treg ratio play critical roles in pathogenic process of chronic obstructive pulmonary disease, 2018, pp.108, 1141~1151
78. Jimenez LA, "PM(10)-exposed macrophages stimulate a proinflammatory response in lung epithelial cells via TNF-alpha", Am J Physiol Lung Cell Mol Physiol, 282, pp.L237~L248 (2002)
79. Russell RE, "Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1by alveolar macrophages from patients with chronic obstructive pulmonary disease", Am J Respir Cell Mol Biol, 26, pp.602~609 (2002)
80. Molet S, "Increase in macrophage elastase(MMP-12)in lungs from patients with chronic obstructive pulmonary disease", Inflamm Res, 54, pp.31~36 (2005)
81. Domagala-Kulawik J, "Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD", Respir Med, 101, pp.1338~1343 (2007)
82. Lofdahl MJ, "Increased intraepithelial T-cells in stable COPD", Respir Med, 102, pp.1812~1818 (2008)
83. Freeman CM, "Cytotoxic potential of lung CD8(+)T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15", J Immunol, 184, pp.6504~6513 (2010)
84. Eapen MS, "Airway inflammation in chronic obstructive pulmonary disease(COPD) : a true paradox", Expert Rev Respir Med, 11, pp.827~839 (2017)
85. Harkins JM, "Anatomy, Abdomen and Pelvis, Sigmoid Colon", StatPearls, ~ (2023)
86. Herath M, "The Role of the Gastrointestinal Mucus System in Intestinal Homeostasis : Implications for Neurological Disorders", Front Cell Infect Microbiol, 10, pp.248~ (2020)
87. Dieterich W, "Influence of low FODMAP and gluten-free diets on disease activity and intestinal microbiota in patients with non-celiac gluten sensitivity", Clin Nutr, 38, pp.697~707 (2019)
88. Thursby E, "Introduction to the human gut microbiota", Biochem J, 474, pp.1823~1836 (2017)
89. Gajendran M, "A comprehensive review and update on ulcerative colitis", Dis Mon, 65, pp.100851~ (2019)
90. Zhang M, "Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease", Front Immunol, 8, pp.942~ (2017)
91. Kobori A, "Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis", J Gastroenterol, 45, pp.999~1007 (2010)
92. Pushparaj PN, "Interleukin-33 exacerbates acute colitis via interleukin-4 in mice", Immunology, 140, pp.70~77 (2013)
93. Waddell A, "IL-33 is produced by colon fibroblasts and differentially regulated in acute and chronic murine colitis", Sci Rep, 11, pp.9575~ (2021)
94. Park JH, "Nuclear IL-33", SMAD signaling axis promotes cancer development in chronic inflammation, 2021, pp.40, e106151~
95. Cayrol C, "IL-33 : an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy", Curr Opin Immunol, 31, pp.31~37 (2014)
96. Perez F, "IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease", Front Immunol, 11, pp.581445~ (2020)
97. Roan F, "Epithelial cell-derived cytokines : more than just signaling the alarm", J Clin Invest, 129, pp.1441~1451 (2019)
98. Miller AM, "Role of IL-33 in inflammation and disease", J Inflamm(Lond), 8, pp.22~ (2011)
99. Smithgall MD, "IL-33 amplifies both Th1-and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells", Int Immunol, 20, pp.1019~1030 (2008)
100. Seidelin JB, "IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis", J Gastroenterol, 50, pp.180~190 (2015)
101. Cheon SY, "IL-33", Regulatory T-Cell Axis Suppresses Skin Fibrosis, 2022, pp.142, 2668~2676
102. Uddin MJ, "The IL-33-ILC2 pathway protects from amebic colitis", Mucosal Immunol, 15, pp.165~175 (2022)
103. Miller AM, "The IL-33", ST2 pathway-A new therapeutic target in cardiovascular disease, 2011, pp.131, 179~186
104. Boothby IC, "Early-life inflammation primes a T helper 2 cell-fibroblast niche in skin", Nature, 599, pp.667~672 (2021)
105. Schiering C, "The alarmin IL-33 promotes regulatory T-cell function in the intestine", Nature, 513, pp.564~568 (2014)
106. Duan L, "Interleukin-33 ameliorates experimental colitis through promoting Th2", Foxp3(+)regulatory T-cell responses in mice, 2012, pp.18, 753~761
107. Ngo Thi Phuong N, "IL-33 Drives Expansion of Type 2 Innate Lymphoid Cells and Regulatory T Cells and Protects Mice From Severe, Acute Colitis", Front Immunol, 12, pp.669787~ (2021)

관련 논문AI추천